 |
|
 |
 |

Home > Company Index > Electronics & Misc. Technology > Scientific & Technical Instruments > IGEN International, Inc.
 |
IGEN International, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Courtroom next stop in IGEN, Roche dispute Aug 13 2001 10:27 AM PDT
Roche Diagnostics sees no quick end to IGEN case Aug 12 2001 12:01 PM PDT
IGEN awaits judge's decision on Roche suit Aug 10 2001 11:22 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
IGEN International uses big words to make an impression. The company's medical diagnostic systems detect biological substances using electrochemiluminescence technology. IGEN's M-Series screening instruments are used by hospitals, universities, and research and industrial laboratories for disease screening, drug development, and genetic testing and research, and in industrial food and water processing and animal health applications. Nearly 55% of IGEN's sales come from Roche Diagnostics (with whom the company is in a licensing dispute). Organon Teknika and Eisai Research also license IGEN's technologies. IGEN is 27%-owned by founder and CEO Samuel Wohlstadter, who also founded Amgen (blood cell therapy).
COMPETITION |
 |
Applied Biosystems Group (ABI)
Beckman Coulter, Inc. (BEC)
PerkinElmer, Inc. (PKI)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: March
2001 Sales (mil.): 31.40
1-Yr. Sales Growth: 51.7%
Employees: 336
Revenue per employee: $93,452.38
KEY PEOPLE |
 |
Samuel J. Wohlstadter
CEO
George V. Migausky
CFO
CONTACT INFO |
 |
16020 Industrial Dr.
Gaithersburg, MD 20877
US
Phone: 301-869-9800
Fax: 301-208-3798
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |